Found: 17
Select item for more details and to access through your institution.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3248, doi. 10.1111/dom.15652
- By:
- Publication type:
- Article
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 262, doi. 10.1111/dom.15312
- By:
- Publication type:
- Article
Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1271, doi. 10.1111/dom.14976
- By:
- Publication type:
- Article
Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 7778, doi. 10.3390/ijms24097778
- By:
- Publication type:
- Article
Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 22, p. 12432, doi. 10.3390/ijms222212432
- By:
- Publication type:
- Article
Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome.
- Published in:
- European Heart Journal Open, 2023, v. 3, n. 6, p. 1, doi. 10.1093/ehjopen/oead098
- By:
- Publication type:
- Article
Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96294-8
- By:
- Publication type:
- Article
Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.885457
- By:
- Publication type:
- Article
Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22343-5
- By:
- Publication type:
- Article
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
- Published in:
- Hypertension Research, 2024, v. 47, n. 3, p. 628, doi. 10.1038/s41440-023-01464-y
- By:
- Publication type:
- Article
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
- Published in:
- Hypertension Research, 2024, v. 47, n. 1, p. 55, doi. 10.1038/s41440-023-01496-4
- By:
- Publication type:
- Article
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.
- Published in:
- Clinical & Experimental Nephrology, 2023, v. 27, n. 7, p. 639, doi. 10.1007/s10157-023-02342-0
- By:
- Publication type:
- Article
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 10, p. 988, doi. 10.1007/s10157-022-02243-8
- By:
- Publication type:
- Article
Updates for Cardio-Kidney Protective Effects by Angiotensin Receptor-Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 8, p. 1, doi. 10.1161/JAHA.122.029565
- By:
- Publication type:
- Article
Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02864-1
- By:
- Publication type:
- Article
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 3, p. 911, doi. 10.1007/s10067-021-05956-5
- By:
- Publication type:
- Article